| Year |
Title |
Altmetric |
| 2022
|
Entrepreneurship and innovation in clinical and translational science.
Journal of Clinical and Translational Science.
6.
2022
|
|
| 2022
|
Exploring COVID-19 Vaccine Hesitancy Among Stakeholders in African American and Latinx Communities in the Deep South Through the Lens of the Health Belief Model.
American Journal of Health Promotion.
36:288-295.
2022
|
|
| 2021
|
Undiagnosed sars-cov-2 seropositivity during the first 6 months of the covid-19 pandemic in the united states.
Science Translational Medicine.
13.
2021
|
|
| 2021
|
Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes.
Nature Genetics.
53:962-971.
2021
|
|
| 2021
|
Re-engineering The Clinical Research Enterprise in Response to COVID-19: The Clinical Translational Science Award (CTSA) experience and proposed playbook for future pandemics..
Journal of Clinical and Translational Science.
5:e96.
2021
|
|
| 2021
|
Building biorepositories in the midst of a pandemic..
Journal of Clinical and Translational Science.
5:e92.
2021
|
|
| 2021
|
Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States.
2021
|
|
| 2021
|
Returning to Growth: One Academic Medical Center's Successful Five-Step Approach to Change Management.
Academic Medicine.
1401-1407.
2021
|
|
| 2020
|
Skewed allelic expression on X chromosome associated with aberrant expression of XIST on systemic lupus erythematosus lymphocytes.
Human Molecular Genetics.
29:2523-2534.
2020
|
|
| 2020
|
Complement genes contribute sex-biased vulnerability in diverse disorders.
Nature.
582:577-581.
2020
|
|
| 2020
|
Population-Specific Patterns of Epigenetic Defects in the B Cell Lineage in Patients With Systemic Lupus Erythematosus.
Arthritis and Rheumatology.
72:282-291.
2020
|
|
| 2020
|
MRLR: Unraveling high-resolution meiotic recombination by linked reads.
Bioinformatics.
36:10-16.
2020
|
|
| 2019
|
Translational research—for the individual and the community.
Journal of Health Care for the Poor and Underserved.
30:79-85.
2019
|
|
| 2019
|
Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39.
Annals of the Rheumatic Diseases.
78:1055-1061.
2019
|
|
| 2019
|
Ifnγ induces epigenetic programming of human t-bethi b cells and promotes tlr7/8 and il-21 induced differentiation.
eLife.
8.
2019
|
|
| 2019
|
Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial.
PLoS Medicine.
16.
2019
|
|
| 2019
|
Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis.
Genes and Immunity.
20:281-292.
2019
|
|
| 2019
|
Genetic influences on susceptibility to rheumatoid arthritis in African-Americans.
Human Molecular Genetics.
28:858-874.
2019
|
|
| 2019
|
Type 1 diabetes risk in African-ancestry participants and utility of an ancestry-specific genetic risk score.
Diabetes Care.
42:406-415.
2019
|
|
| 2018
|
Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans.
Human Molecular Genetics.
27:3813-3824.
2018
|
|
| 2018
|
Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1–second gene interactions.
Kidney International.
94:599-607.
2018
|
|
| 2018
|
Trans-ethnic mapping of BANK1 identifies two independent SLE-Risk linkage groups enriched for co-transcriptional splicing marks.
International Journal of Molecular Sciences.
19.
2018
|
|
| 2018
|
A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus.
Human Molecular Genetics.
27:2392-2404.
2018
|
|
| 2018
|
Discovery and validation of circulating biomarkers of colorectal adenoma by high-depth small RNA sequencing.
Clinical Cancer Research.
24:2092-2099.
2018
|
|
| 2017
|
Transancestral mapping and genetic load in systemic lupus erythematosus.
Nature Communications.
8.
2017
|
|
| 2017
|
Regulation of FcRγ function by site-specific serine phosphorylation.
Journal of Leukocyte Biology.
101:421-428.
2017
|
|
| 2016
|
Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production.
Annals of the Rheumatic Diseases.
75:2007-2013.
2016
|
|
| 2016
|
Prospecting for precision: Promises for personalized medicine.
Journal of Rheumatology.
43:999-1000.
2016
|
|
| 2016
|
Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans.
Arthritis and Rheumatology.
68:1197-1209.
2016
|
|
| 2016
|
X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome.
Arthritis and Rheumatology.
68:1290-1300.
2016
|
|
| 2016
|
Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture.
Arthritis and Rheumatology.
68:932-943.
2016
|
|
| 2016
|
Estimation of cell-type composition including T and B cell subtypes for whole blood methylation microarray data.
Frontiers in Genetics.
7.
2016
|
|
| 2016
|
Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA.
Annals of the Rheumatic Diseases.
75:242-252.
2016
|
|
| 2015
|
Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus.
Clinical Immunology.
161:157-162.
2015
|
|
| 2015
|
Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African Americans.
Gastroenterology.
149:1575-1586.
2015
|
|
| 2015
|
Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort.
Clinical Rheumatology.
34:1217-1223.
2015
|
|
| 2015
|
Editorial: The road traveled: Genomics and biomarkers in antineutrophil cytoplasmic antibody-associated vasculitis.
Arthritis and Rheumatology.
67:1700-1702.
2015
|
|
| 2015
|
Lupus risk variant increases pSTAT1 binding and decreases ETS1 expression.
American Journal of Human Genetics.
96:731-739.
2015
|
|
| 2015
|
Lack of association of the APOL1 G3 haplotype in African Americans with ESRD.
Journal of the American Society of Nephrology.
26:1021-1025.
2015
|
|
| 2015
|
Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study.
Genes and Immunity.
16:142-150.
2015
|
|
| 2015
|
Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.
Genes and Immunity.
16:15-23.
2015
|
|
| 2015
|
The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share.
Human Molecular Genetics.
24:582-596.
2015
|
|
| 2015
|
Blocking of targeted microRNAs from next-generation sequencing libraries.
Nucleic Acids Research.
43.
2015
|
|
| 2014
|
Lupus nephritis susceptibility loci in women with systemic lupus erythematosus.
Journal of the American Society of Nephrology.
25:2859-2870.
2014
|
|
| 2014
|
GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region.
Genes and Immunity.
15:347-354.
2014
|
|
| 2014
|
Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription.
American Journal of Human Genetics.
94:586-598.
2014
|
|
| 2014
|
MHC associations with clinical and autoantibody manifestations in European SLE..
Genes and Immunity.
15:210-217.
2014
|
|
| 2014
|
Targeting the Fc receptor in autoimmune disease.
Expert Opinion on Therapeutic Targets.
18:335-350.
2014
|
|
| 2014
|
Brief report: A polymorphism in TLR2 is associated with arterial thrombosis in a multiethnic population of patients with systemic lupus erythematosus.
Arthritis and Rheumatology.
66:1882-1887.
2014
|
|
| 2014
|
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
Arthritis and Rheumatology.
66:390-396.
2014
|
|
| 2014
|
Fcγ receptor IIIa single-nucleotide polymorphisms and haplotypes affect human IgG binding and are associated with lupus nephritis in African Americans.
Arthritis and Rheumatology.
66:1291-1299.
2014
|
|
| 2014
|
Human FcR polymorphism and disease.
Current Topics in Microbiology and Immunology.
382:275-302.
2014
|
|
| 2014
|
Lupus risk variants in the PXK locus alter B-cell receptor internalization.
Frontiers in Genetics.
5.
2014
|
|
| 2013
|
FcγRIIIa SNPs and haplotypes affect human IgG binding and association with lupus nephritis in African Americans..
Arthritis and Rheumatism.
2013
|
|
| 2013
|
Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses.
Science Translational Medicine.
5.
2013
|
|
| 2013
|
ABIN1 dysfunction as a genetic basis for lupus nephritis.
Journal of the American Society of Nephrology.
24:1743-1754.
2013
|
|
| 2013
|
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci..
Human Molecular Genetics.
22:4021-4029.
2013
|
|
| 2013
|
Preferential Binding to Elk-1 by SLE-Associated IL10 Risk Allele Upregulates IL10 Expression.
PLoS Genetics.
9.
2013
|
|
| 2013
|
PTPN22 Association in Systemic Lupus Erythematosus (SLE) with Respect to Individual Ancestry and Clinical Sub-Phenotypes.
PLoS One.
8.
2013
|
|
| 2013
|
Genome-Wide DNA Methylation Analysis of Systemic Lupus Erythematosus Reveals Persistent Hypomethylation of Interferon Genes and Compositional Changes to CD4+ T-cell Populations.
PLoS Genetics.
9.
2013
|
|
| 2013
|
Trans-Ancestral Studies Fine Map the SLE-Susceptibility Locus TNFSF4.
PLoS Genetics.
9.
2013
|
|
| 2013
|
Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry.
Journal of Rheumatology.
40:842-849.
2013
|
|
| 2013
|
Genomic Copy Number Variants: Evidence for Association with Antibody Response to Anthrax Vaccine Adsorbed.
PLoS One.
8.
2013
|
|
| 2013
|
Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis.
PLoS Genetics.
9.
2013
|
|
| 2013
|
Fine mapping of Xq28: Both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups.
Annals of the Rheumatic Diseases.
72:437-444.
2013
|
|
| 2013
|
Admixture Mapping in Lupus Identifies Multiple Functional Variants within IFIH1 Associated with Apoptosis, Inflammation, and Autoantibody Production.
PLoS Genetics.
9.
2013
|
|
| 2013
|
MicroRNA-3148 Modulates Allelic Expression of Toll-Like Receptor 7 Variant Associated with Systemic Lupus Erythematosus.
PLoS Genetics.
9.
2013
|
|
| 2013
|
Single-nucleotide polymorphisms in VKORC1 are risk factors for systemic lupus erythematosus in Asians.
Arthritis and Rheumatism.
65:211-215.
2013
|
|
| 2012
|
Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans..
American Journal of Human Genetics.
91:778-793.
2012
|
|
| 2012
|
Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus.
Arthritis and Rheumatism.
64:3695-3705.
2012
|
|
| 2012
|
CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation.
Nature Genetics.
44:1227-1230.
2012
|
|
| 2012
|
Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations.
Arthritis and Rheumatism.
64:3687-3694.
2012
|
|
| 2012
|
The unique cytoplasmic domain of human FcγRIIIA regulates receptor-mediated function.
Journal of Immunology.
189:4284-4294.
2012
|
|
| 2012
|
Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries.
Annals of the Rheumatic Diseases.
71:1809-1814.
2012
|
|
| 2012
|
Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility.
PLoS One.
7.
2012
|
|
| 2012
|
Genetic risk factors for thrombosis in systemic lupus erythematosus.
Journal of Rheumatology.
39:1603-1610.
2012
|
|
| 2012
|
A genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine Adsorbed.
Vaccine.
30:4778-4784.
2012
|
|
| 2012
|
A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus.
Genes and Immunity.
13:380-387.
2012
|
|
| 2012
|
Evaluation of TRAF6 in a large multiancestral lupus cohort.
Arthritis and Rheumatism.
64:1960-1969.
2012
|
|
| 2012
|
Analysis of autosomal genes reveals gene-sex interactions and higher total genetic risk in men with systemic lupus erythematosus.
Annals of the Rheumatic Diseases.
71:694-699.
2012
|
|
| 2012
|
Association of single-nucleotide polymorphisms in CCR6, TAGAP, and TNFAIP3 with rheumatoid arthritis in African Americans.
Arthritis and Rheumatism.
64:1355-1358.
2012
|
|
| 2012
|
Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study.
American Journal of Human Genetics.
90:648-660.
2012
|
|
| 2012
|
Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis.
Genes and Immunity.
13:232-238.
2012
|
|
| 2012
|
IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
Annals of the Rheumatic Diseases.
71:463-468.
2012
|
|
| 2012
|
Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus.
Arthritis and Rheumatism.
64:485-492.
2012
|
|
| 2012
|
Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase.
Proceedings of the National Academy of Sciences of USA.
109.
2012
|
|
| 2012
|
Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort..
Arthritis Care and Research.
64:704-712.
2012
|
|
| 2012
|
Gene-gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus..
Arthritis and Rheumatism.
64:222-231.
2012
|
|
| 2012
|
Serine phosphorylation of FcγRI cytoplasmic domain directs lipid raft localization and interaction with protein 4.1G.
Journal of Leukocyte Biology.
91:97-103.
2012
|
|
| 2012
|
Treatment of arthritis by macrophage depletion and immunomodulation: testing an apoptosis-mediated therapy in a humanized death receptor mouse model..
Arthritis and Rheumatism.
64:1098-1109.
2012
|
|
| 2011
|
IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis.
Proceedings of the National Academy of Sciences of USA.
108:20736-20741.
2011
|
|
| 2011
|
A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap.
PLoS Genetics.
7.
2011
|
|
| 2011
|
FAS mRNA editing in human systemic lupus erythematosus.
Human Mutation.
32:1268-1277.
2011
|
|
| 2011
|
Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study.
Arthritis and Rheumatism.
63:3493-3501.
2011
|
|
| 2011
|
Human FasL gene is a target of β-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions.
PLoS One.
6.
2011
|
|
| 2011
|
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus.
Annals of the Rheumatic Diseases.
70:1752-1757.
2011
|
|
| 2011
|
Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups.
Arthritis and Rheumatism.
63:2755-2763.
2011
|
|
| 2011
|
The role of HLA-DR-DQ haplotypes in variable antibody responses to Anthrax Vaccine Adsorbed.
Genes and Immunity.
12:457-465.
2011
|
|
| 2011
|
Genetic analyses of interferon pathway-related genes reveal multiple new loci associated with systemic lupus erythematosus.
Arthritis and Rheumatism.
63:2049-2057.
2011
|
|
| 2011
|
Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort.
Genes and Immunity.
12:270-279.
2011
|
|
| 2011
|
Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21.
Arthritis and Rheumatism.
63:1689-1697.
2011
|
|
| 2011
|
Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility..
PLoS Genetics.
7:e1002079.
2011
|
|
| 2011
|
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus.
Nature Genetics.
43:253-258.
2011
|
|
| 2011
|
Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production..
PLoS Genetics.
7:e1001323.
2011
|
|
| 2011
|
The functional polymorphism 844 A>G in Fc αRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility.
Journal of Rheumatology.
38:446-449.
2011
|
|
| 2011
|
Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study.
American Journal of Human Genetics.
88:83-91.
2011
|
|
| 2010
|
Most common single-nucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheumatoid arthritis in African Americans.
Arthritis Care and Research.
62:3547-3553.
2010
|
|
| 2010
|
The role of genetic variation near interferon-kappa in systemic lupus erythematosus.
Journal of Biomedicine and Biotechnology.
2010.
2010
|
|
| 2010
|
ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry.
Annals of the Rheumatic Diseases.
69:1329-1332.
2010
|
|
| 2010
|
The non-muscle myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans.
American Journal of Nephrology.
32:66-72.
2010
|
|
| 2010
|
Pathways: Strategies for susceptibility genes in SLE.
Autoimmunity Reviews.
9:473-476.
2010
|
|
| 2010
|
Genetic variants of STAT4 associated with rheumatoid arthritis in persons of Asian and European ancestry do not replicate in African Americans.
Annals of the Rheumatic Diseases.
69:625-626.
2010
|
|
| 2010
|
The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases.
Annals of the Rheumatic Diseases.
69:696-699.
2010
|
|
| 2010
|
Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis.
Seminars in Nephrology.
30:164-176.
2010
|
|
| 2010
|
Wegener's granulomatosis: A model of auto-antibodies in mucosal autoimmunity.
Clinical Immunology.
134:104-112.
2010
|
|
| 2010
|
Erratum: Genetic associations of LYN with systemic lupus erythematosus (Genes and Immunity (2009) 10 (397-403) DOI: 10.1038/gene.2009.19).
Genes and Immunity.
11:98.
2010
|
|
| 2009
|
A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus.
Nature Genetics.
41:1228-1233.
2009
|
|
| 2009
|
The FCRL3 -169CT promoter single-nucleotide polymorphism, which is associated with systemic lupus erythematosus in a Japanese population, predicts expression of receptor protein on CD19+ B cells.
Arthritis and Rheumatism.
60:3510-3512.
2009
|
|
| 2009
|
Factors associated with arterial vascular events in PROFILE: A multiethnic lupus cohort.
Lupus.
18:958-965.
2009
|
|
| 2009
|
Erratum: Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing (Genes and Immunity (2009) vol. 10 (457-469) 10.1038/gene.2009.27).
Genes and Immunity.
10:606.
2009
|
|
| 2009
|
A polymorphism within IL21R confers risk for systemic lupus erythematosus.
Arthritis and Rheumatism.
60:2402-2407.
2009
|
|
| 2009
|
Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived population.
Genes and Immunity.
10:531-538.
2009
|
|
| 2009
|
Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans.
Journal of Clinical Investigation.
119:911-923.
2009
|
|
| 2009
|
Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus.
Arthritis and Rheumatism.
60:1076-1084.
2009
|
|
| 2009
|
Evaluation of imputation-based association in and around the integrin-α-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE).
Human Molecular Genetics.
18:1171-1180.
2009
|
|
| 2009
|
An african ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in african americans.
PLoS Genetics.
5.
2009
|
|
| 2009
|
Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing.
Genes and Immunity.
10:457-469.
2009
|
|
| 2009
|
Genetic associations of LYN with systemic lupus erythematosus.
Genes and Immunity.
10:397-403.
2009
|
|
| 2009
|
Retraction: an African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans..
PLoS Genetics.
5.
2009
|
|
| 2008
|
Functional expression of IgA receptor FcαRI on human platelets.
Journal of Leukocyte Biology.
84:1492-1500.
2008
|
|
| 2008
|
Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus.
Annals of the Rheumatic Diseases.
67:1724-1731.
2008
|
|
| 2008
|
Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort.
Arthritis Care and Research.
59:1332-1340.
2008
|
|
| 2008
|
Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: Support for the notion of a gene-dose effect from the X chromosome.
Arthritis and Rheumatism.
58:2511-2517.
2008
|
|
| 2008
|
Immune opsonins modulate BLyS/BAFF release in a receptor-specific fashion.
Journal of Immunology.
181:1012-1018.
2008
|
|
| 2008
|
Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort.
Lupus.
17:177-184.
2008
|
|
| 2008
|
Genetic variation in the CRP promoter: Association with systemic lupus erythematosus.
Human Molecular Genetics.
17:1147-1155.
2008
|
|
| 2008
|
Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans.
Genes and Immunity.
9:187-194.
2008
|
|
| 2008
|
Common variants within MECP2 confer risk of systemic lupus erythematosus.
PLoS One.
3.
2008
|
|
| 2008
|
A nonsynonymous functional variant in integrin-αM (encoded by ITGAM) is associated with systemic lupus erythematosus.
Nature Genetics.
40:152-154.
2008
|
|
| 2008
|
Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci.
Nature Genetics.
40:204-210.
2008
|
|
| 2008
|
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.
Journal of Clinical Investigation.
118:629-639.
2008
|
|
| 2007
|
Fc receptor genes and the systemic lupus erythematosus diathesis.
Autoimmunity.
40:567-581.
2007
|
|
| 2007
|
Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjects.
Arthritis and Rheumatism.
56:3375-3378.
2007
|
|
| 2007
|
Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity.
BBA: Molecular Cell Research.
1773:1116-1123.
2007
|
|
| 2007
|
Tumor exosomes inhibit differentiation of bone marrow dendritic cells.
Journal of Immunology.
178:6867-6875.
2007
|
|
| 2007
|
FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA..
Journal of Immunology.
178:3973-3982.
2007
|
|
| 2007
|
FcαRI (CD89) alleles determine the proinflammatory potential of serum IgA.
Journal of Immunology.
178:3973-3982.
2007
|
|
| 2007
|
Expression profile of FcγRIIb on leukocytes and its dysregulation in systemic lupus erythematosus.
Journal of Immunology.
178:3272-3280.
2007
|
|
| 2007
|
Biologic therapies in rheumatology: Lessons learned, future directions.
Nature Reviews Drug Discovery.
6:75-92.
2007
|
|
| 2006
|
Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor γ chain to induce innate immune responses.
Journal of Biological Chemistry.
281:38854-38866.
2006
|
|
| 2006
|
Association of a transmembrane polymorphism of Fcγ receptor IIb (FCGR2B) with systemic lupus erythematosus in Taiwanese patients.
Arthritis and Rheumatism.
54:3908-3917.
2006
|
|
| 2006
|
Time to renal disease and end-stage renal disease in PROFILE: A multiethnic lupus cohort.
PLoS Medicine.
3:1949-1956.
2006
|
|
| 2006
|
Regional admixture mapping and structured association testing: Conceptual unification and an extensible general linear model.
PLoS Genetics.
2:1254-1264.
2006
|
|
| 2006
|
Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function.
Cancer Research.
66:8520-8528.
2006
|
|
| 2006
|
Regional admixture mapping and structured association testing: conceptual unification and an extensible general linear model..
PLoS Genetics.
2.
2006
|
|
| 2006
|
Erratum: A membrane form of TNF-α presented by exosomes delays T cell activation-induced cell death (Journal of Immunology (2006) 176 (7385-7393)).
Journal of Immunology.
177:2025.
2006
|
|
| 2006
|
A membrane form of TNF-α presented by exosomes delays T cell activation-induced cell death.
Journal of Immunology.
176:7385-7393.
2006
|
|
| 2006
|
Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function.
Journal of Immunology.
176:1375-1385.
2006
|
|
| 2006
|
No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome.
Arthritis Research and Therapy.
8.
2006
|
|
| 2006
|
JAB1 determines the response of rheumatoid arthritis synovial fibroblasts to tumor necrosis factor-α.
American Journal of Pathology.
169:889-902.
2006
|
|
| 2005
|
Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus.
Arthritis and Rheumatism.
52:3943-3954.
2005
|
|
| 2005
|
SLE: Challenges and candidates in human disease.
Trends in Immunology.
26:580-586.
2005
|
|
| 2005
|
Genetics of susceptibility and severity in systemic lupus erythematosus.
Current Opinion in Rheumatology.
17:529-537.
2005
|
|
| 2005
|
Correlation of serum B lymphocyte stimulator and β2 microglobulin with autoantibody secretion and systemic involvement in primary Sjögren's syndrome.
Annals of the Rheumatic Diseases.
64:1050-1055.
2005
|
|
| 2005
|
Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: Association between C-reactive protein (CRP) gene polymorphisms and vascular events.
Rheumatology.
44:864-868.
2005
|
|
| 2005
|
Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level.
Journal of Molecular Medicine.
83:440-447.
2005
|
|
| 2005
|
Cleavage of p53-vimentin complex enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of rheumatoid arthritis synovial fibroblasts.
American Journal of Pathology.
167:705-719.
2005
|
|
| 2004
|
Genetic risk factors for infection in patients with early rheumatoid arthritis.
Genes and Immunity.
5:641-647.
2004
|
|
| 2004
|
Differential gene expression modulated by the cytoplasmic domain of FcγRIa (CD64) α-chain.
Journal of Immunology.
173:6211-6219.
2004
|
|
| 2004
|
The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.
Arthritis and Rheumatism.
50:2750-2756.
2004
|
|
| 2004
|
An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.
Journal of Virology.
78:7217-7226.
2004
|
|
| 2004
|
Associations, populations, and the truth: Recommendations for genetic association studies in Arthritis & Rheumatism.
Arthritis and Rheumatism.
50:2066-2071.
2004
|
|
| 2004
|
A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus.
Journal of Immunology.
172:7186-7191.
2004
|
|
| 2004
|
A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIb alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function.
Journal of Immunology.
172:7192-7199.
2004
|
|
| 2004
|
Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.
Arthritis and Rheumatism.
50:1884-1896.
2004
|
|
| 2003
|
Fc gamma RIIIb allele-sensitive release of alpha-defensins: anti-neutrophil cytoplasmic antibody-induced release of chemotaxins..
Journal of Immunology.
171:6090-6096.
2003
|
|
| 2003
|
FcγRIIIb Allele-Sensitive Release of α-Defensins: Anti-Neutrophil Cytoplasmic Antibody-Induced Release of Chemotaxins.
Journal of Immunology.
171:6090-6096.
2003
|
|
| 2003
|
Study of host and virological factors of patients with chronic HCV infection and associated laboratory or clinical autoimmune manifestations.
Clinical and Experimental Rheumatology.
21.
2003
|
|
| 2003
|
A Novel Polymorphism in the Fcγ Receptor IIB (CD32B) Transmembrane Region Alters Receptor Signaling.
Arthritis and Rheumatism.
48:3242-3252.
2003
|
|
| 2003
|
Study of host and virological factors of patients with chronic HCV infection and associated laboratory or clinical autoimmune manifestations..
Clinical and Experimental Rheumatology.
21:S101-S111.
2003
|
|
| 2003
|
Can the weighted criteria improve our ability to capture a larger number of lupus patients into observational and interventional studies? A comparison with the American College of Rheumatology Criteria.
Lupus.
12:468-470.
2003
|
|
| 2003
|
FcγRs modulate cytotoxicity of anti-Fas antibodies: Implications for agonistic antibody-based therapeutics.
Journal of Immunology.
171:562-568.
2003
|
|
| 2003
|
TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis.
Journal of Immunology.
171:1061-1069.
2003
|
|
| 2003
|
Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway.
Oncogene.
22:2034-2044.
2003
|
|
| 2003
|
The FcγRIIIA-F158 allele is a risk factor for the development of lupus nephritis: A meta-analysis.
Kidney International.
63:1475-1482.
2003
|
|
| 2003
|
The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome.
Annals of the Rheumatic Diseases.
62:168-171.
2003
|
|
| 2003
|
A novel polymorphic CAAT/enhancer-binding protein β element in the FasL gene promoter alters Fas ligand expression: A candidate background gene in African American systemic lupus erythematosus patients.
Journal of Immunology.
170:132-138.
2003
|
|
| 2003
|
BLyS and B cell autoimmunity..
Current directions in autoimmunity.
6:21-37.
2003
|
|
| 2002
|
Fc receptor homologs: Newest members of a remarkably diverse Fc receptor gene family.
Immunological Reviews.
190:123-136.
2002
|
|
| 2002
|
Diversity and duplicity: Human Fcγ receptors in host defense and autoimmunity.
Immunologic Research.
26:177-189.
2002
|
|
| 2002
|
Immunobiology of tumor necrosis factor receptor superfamily.
Immunologic Research.
26:323-336.
2002
|
|
| 2002
|
The CY domain of the FcγRIa α-chain (CD64) alters γ-chain tyrosine-based signaling and phagocytosis.
Journal of Biological Chemistry.
277:41287-41293.
2002
|
|
| 2002
|
Cytokine gene polymorphism in human disease: On-line databases, supplement 2.
Genes and Immunity.
3:313-330.
2002
|
|
| 2002
|
Genetic linkage and association of Fcγ receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus.
Arthritis and Rheumatism.
46:2132-2140.
2002
|
|
| 2002
|
Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene.
Genes and Immunity.
3:14-19.
2002
|
|
| 2002
|
Baseline characteristics of a multiethnic lupus cohort: PROFILE.
Lupus.
11:95-101.
2002
|
|
| 2002
|
Baseline characteristics of a multiethnic lupus cohort: PROFILE.
Lupus.
11:95-101.
2002
|
|
| 2002
|
Conservation of FcεRI gamma chain coding region in normals and in SLE patients.
Lupus.
11:42-45.
2002
|
|
| 2002
|
Erratum: Baseline characteristics of a multiethnic lupus cohort: PROFILE (Lupus (2002) 11 (95)).
Lupus.
11:402.
2002
|
|
| 2002
|
Genomic organization of classical human low-affinity Fcγ receptor genes.
Genes and Immunity.
3:S51-S56.
2002
|
|
| 2001
|
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.
Nature Medicine.
7:954-960.
2001
|
|
| 2001
|
The Influence of Genetic Variation in Fcγ RIIIb (NA1/NA2) on Neutrophil Specific Granule Release
2001
|
|
| 2001
|
Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus.
Journal of Immunology.
166:3915-3922.
2001
|
|
| 2001
|
Prospects for autoimmune disease: Research advances in systemic lupus erythematosus..
JAMA: Journal of the American Medical Association.
285:650-652.
2001
|
|
| 2001
|
Research advances in systemic lupus erythematosus.
JAMA: Journal of the American Medical Association.
285:650-651.
2001
|
|
| 2001
|
Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus.
Journal of Immunology.
166:6-10.
2001
|
|
| 2001
|
Cytokine gene polymorphism in human disease: On-line databases, Supplement 1.
Genes and Immunity.
2:61-70.
2001
|
|
| 2001
|
Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.
Hepatology.
33:708-712.
2001
|
|
| 2001
|
Treatment of lupus with corticosteroids.
Lupus.
10:140-147.
2001
|
|
| 2000
|
C-reactive protein binding to FcγRIIa on human monocytes and neutrophils is allele-specific.
Journal of Clinical Investigation.
105:369-376.
2000
|
|
| 2000
|
Genome scan of human systemic lupus erythematosus by regression modeling: Evidence of linkage and epistasis at 4p16-15.2.
American Journal of Human Genetics.
67:1460-1469.
2000
|
|
| 1999
|
Transcriptional regulation of Fas gene expression by GA-binding protein and AP-1 in T cell antigen receptor · CD3 complex-stimulated T cells.
Journal of Biological Chemistry.
274:35203-35210.
1999
|
|
| 1999
|
Single-nucleotide polymorphisms of T cell receptor zeta chain in patients with systemic lupus erythematosus..
Arthritis and Rheumatism.
42:2601-2605.
1999
|
|
| 1999
|
Single-nucleotide polymorphisms of T cell receptor ζ chain in patients with systemic lupus erythematosus.
Arthritis and Rheumatism.
42:2601-2605.
1999
|
|
| 1999
|
The cytoplasmic domain of human FcγRIa alters the functional properties of the FcγRI·γ-chain receptor complex.
Journal of Biological Chemistry.
274:30328-30333.
1999
|
|
| 1999
|
Cytokine gene polymorphism in human disease: On-line databases.
Genes and Immunity.
1:3-19.
1999
|
|
| 1999
|
Genetics of human lupus..
Current directions in autoimmunity.
1:99-120.
1999
|
|
| 1998
|
Antineutrophil cytoplasmic antibodies preferentially engage FcγrIIIb on human neutrophils.
Journal of Immunology.
161:6909-6914.
1998
|
|
| 1998
|
Cutting edge: Differential CD5-dependent regulation of CD5-associated CK2 activity in mature and immature T cells: Implication on TCR/CD3-mediated activation.
Journal of Immunology.
161:5817-5820.
1998
|
|
| 1998
|
Differential CD5-dependent regulation of CD5-associated CK2 activity in mature and immature T cells: implication on TCR/CD3-mediated activation..
Journal of Immunology.
161:5817-5820.
1998
|
|
| 1998
|
Regulation of casein kinase 2 by direct interaction with cell surface receptor CD5.
Journal of Biological Chemistry.
273:19183-19189.
1998
|
|
| 1998
|
Differential regulation of human neutrophil FcγRIIa (CD32) and FcγRIIIb (CD16)-induced Ca2+ transients.
Journal of Biological Chemistry.
273:8071-8079.
1998
|
|
| 1998
|
CD5 regulates Casein Kinase 2 (CK2) by direct interaction with the holoenzyme.
The FASEB Journal.
12.
1998
|
|
| 1998
|
Analysis of FcγRII gene polymorphisms in Wegener's granulomatosis.
Experimental and clinical immunogenetics.
14:183-195.
1998
|
|
| 1998
|
Localization of FCGR1 encoding Fcγ receptor class I in primates: Molecular evidence for two pericentric inversions during the evolution of human chromosome 1.
Cytogenetic and Genome Research.
82:71-74.
1998
|
|
| 1997
|
Cell Type-Specific Glycoforms of FcγRIIIa (CD16): Differential Ligand Binding.
Journal of Immunology.
159:3849-3857.
1997
|
|
| 1997
|
Cross-Linking of Fcγ Receptor IIa and Fcγ Receptor IIIb Induces Different Proadhesive Phenotypes on Human Neutrophils.
Journal of Immunology.
159:3940-3948.
1997
|
|
| 1997
|
A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.
Journal of Clinical Investigation.
100:1059-1070.
1997
|
|
| 1997
|
Antibodies to C1q in systemic lupus erythematosus: Characteristics and relation to FcγRIIA alleles.
Kidney International.
52:1375-1380.
1997
|
|
| 1996
|
Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans..
Journal of Clinical Investigation.
97:1348-1354.
1996
|
|
| 1996
|
FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans.
Journal of Clinical Investigation.
97:1348-1354.
1996
|
|
| 1995
|
Differential Regulation of Fcgamma Receptor Isoforms: Implications for Therapeutic Intervention..
American Journal of Therapeutics.
2:777-781.
1995
|
|
| 1995
|
Fc gamma receptor IIIb enhances Fc gamma receptor IIa function in an oxidant-dependent and allele-sensitive manner..
Journal of Clinical Investigation.
95:2877-2885.
1995
|
|
| 1995
|
B cell differentiation factor-induced human B cell maturation: Stimulation of intracellular calcium release.
Cellular Immunology.
164:227-233.
1995
|
|
| 1995
|
Fcγ receptor IIIb enhances Fcγ receptor IIa function in an oxidant-dependent and allele-sensitive manner.
Journal of Clinical Investigation.
95:2877-2885.
1995
|
|
| 1995
|
Receptors for immunoglobulin g molecular diversity and implications for disease.
Arthritis and Rheumatism.
38:306-314.
1995
|
|
| 1995
|
The Ca2+ dependence of human Fcγ receptor-initiated phagocytosis.
Journal of Biological Chemistry.
270:22301-22307.
1995
|
|
| 1994
|
Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via FcγRIIa.
Journal of Immunology.
153:1271-1280.
1994
|
|
| 1994
|
Ciprofloxacin reactions mimicking lupus flares.
Arthritis and Rheumatism.
37:1112-1113.
1994
|
|
| 1994
|
Glucocorticoids.
Current Opinion in Rheumatology.
6:273-280.
1994
|
|
| 1994
|
Modulation of Fcγ and complement receptor function by the glycosyl- phosphatidylinositol-anchored form of FcγRIII.
Journal of Immunology.
152:5826-5835.
1994
|
|
| 1994
|
The high affinity Fcγ receptor [CD64) induces phagocytosis in the absence of its cytoplasmic domain: The γ subunit of FcγRIIIA imparts phagocytic function to FcγRI.
Experimental Hematology.
22:599-606.
1994
|
|
| 1993
|
Human mononuclear phagocytes express adenosine A1 receptors: A novel mechanism for differential regulation of Fcγ receptor function.
Journal of Immunology.
151:2775-2785.
1993
|
|
| 1992
|
Functional capacity of Fcγ receptor III (CD16) on human neutrophils.
Immunologic Research.
11:239-251.
1992
|
|
| 1992
|
Allelic polymorphisms of human Fcγ receptor IIA and Fcγ receptor IIIB: Independent mechanisms for differences in human phagocyte function.
Journal of Clinical Investigation.
89:1274-1281.
1992
|
|
| 1992
|
Functional characterization of non‐human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system.
European Journal of Immunology.
22:1333-1339.
1992
|
|
| 1992
|
Glucocorticoid therapy for rheumatic diseases.
Current Opinion in Rheumatology.
4:325-331.
1992
|
|
| 1992
|
Novel Fcγ receptor I family gene products in human mononuclear cells.
Journal of Clinical Investigation.
90:2102-2109.
1992
|
|
| 1992
|
Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia.
Journal of Rheumatology.
19:1191-1194.
1992
|
|
| 1992
|
Receptor specific probes for the study of Fcγ receptor specific function.
Journal of Immunological Methods.
148:179-187.
1992
|
|
| 1991
|
Fc gamma receptor III induces actin polymerization in human neutrophils and primes phagocytosis mediated by Fc gamma receptor II..
Journal of Immunology.
146:997-1004.
1991
|
|
| 1991
|
A single amino acid distinguishes the high‐responder from the low‐responder form of Fc receptor II on human monocytes.
European Journal of Immunology.
21:1911-1916.
1991
|
|
| 1991
|
Fcγ receptor III induces actin polymerization in human neutrophils and primes phagocytosis mediated by Fcγ receptor II.
Journal of Immunology.
146:997-1004.
1991
|
|
| 1991
|
Intravenous Anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity, and mechanism of effect.
Blood.
77:1884-1893.
1991
|
|
| 1991
|
Mechanisms of action, dosage schedules, and side effects of steroid therapy.
Current Opinion in Rheumatology.
3:373-379.
1991
|
|
| 1991
|
Of mice and men: Insights into the complexity of mononuclear phagocyte system blockade provided by autoimmune mouse strains.
Translational Research: the journal of laboratory and clinical medicine.
117:173-174.
1991
|
|
| 1991
|
Of mice and men: Insights into the complexity of mononuclear phagocyte system blockade provided by autoimmune mouse strains.
Translational Research: the journal of laboratory and clinical medicine.
117:171-172.
1991
|
|
| 1991
|
Preferential expression of human FcγRIII(PMN) (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
Journal of Clinical Investigation.
87:58-67.
1991
|
|
| 1991
|
Regulation of phagocytosis and [Ca2+]i flux by distinct regions of an Fc receptor.
Science.
254:1785-1788.
1991
|
|
| 1990
|
Fc gamma RIII expressed on cultured monocytes is a N-glycosylated transmembrane protein distinct from Fc gamma RIII expressed on natural killer cells..
Journal of Immunology.
144:4729-4734.
1990
|
|
| 1990
|
Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities..
Journal of Clinical Investigation.
85:1287-1295.
1990
|
|
| 1990
|
The glycosyl phosphatidylinositol-linked fcγRIIIPMN mediates transmembrane signaling events distinct from FCγRII.
Journal of Experimental Medicine.
171:1239-1255.
1990
|
|
| 1990
|
Fcγ receptor III on human neutrophils: Allelic variants have functionally distinct capacities.
Journal of Clinical Investigation.
85:1287-1295.
1990
|
|
| 1990
|
FcγRIII expressed on cultured monocytes is an N-glycosylated transmembrane protein distinct from FcγRIII expressed on natural killer cells.
Journal of Immunology.
144:4729-4734.
1990
|
|
| 1990
|
Steroids.
Current Opinion in Rheumatology.
2:510-516.
1990
|
|
| 1989
|
The role of Fcγ receptors in mononuclear phagocyte system function.
Clinical and Experimental Rheumatology.
7.
1989
|
|
| 1989
|
Carbohydrates on human Fcγ receptors. Interdependence of the classical IgG and nonclassical lectin-binding sites on human FcγRIII expressed on neutrophils.
Journal of Immunology.
142:3923-3930.
1989
|
|
| 1989
|
Glucocorticoids.
Current Opinion in Rheumatology.
1:92-97.
1989
|
|
| 1989
|
High‐Dose, pulse intravenous methylprednisolone enhances fcγ receptor–mediated mononuclear phagocyte function in systemic lupus erythematosus.
Arthritis and Rheumatism.
32:717-725.
1989
|
|
| 1989
|
Human FcγRIII (CD16). Isoforms with distinct allelic expression, extracellular domains, and membrane linkages on polymorphonuclear and natural killer cells.
Journal of Immunology.
143:1642-1649.
1989
|
|
| 1989
|
In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees.
Journal of Clinical Investigation.
84:962-970.
1989
|
|
| 1988
|
Treatment. Corticosteroids and anti-inflammatory drugs.
Rheumatic Disease Clinics of North America.
14:203-221.
1988
|
|
| 1987
|
Immune complexes in the rheumatic diseases..
Rheumatic Disease Clinics of North America.
13:583-596.
1987
|
|
| 1987
|
Differences among immune complexes: Association of Clq in SLE immune complexes with renal disease.
Journal of Immunology.
138:739-745.
1987
|
|
| 1987
|
Gammaglobulin for intravenous use induces an Fc γ receptor-specific decrement in phagocytosis by blood monocytes.
Clinical immunology and immunopathology.
43:23-33.
1987
|
|
| 1987
|
Mononuclear phagocyte system complement receptor dysfunction in rheumatoid arthritis.
Journal of Immunology.
138:4165-4168.
1987
|
|
| 1986
|
Blockade of clearance of immune complexes by an anti-fcγ receptor monoclonal antibody.
Journal of Experimental Medicine.
164:474-489.
1986
|
|
| 1986
|
Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor Antibody.
New England Journal of Medicine.
314:1236-1239.
1986
|
|
| 1986
|
Methyldopa and Reticuloendothelial Function.
New England Journal of Medicine.
314:248-249.
1986
|
|
| 1986
|
Altered phagocytosis by monocytes from HLA-DR2 and DR3-positive healthy adults is Fc γ receptor specific.
Journal of Immunology.
136:3625-3630.
1986
|
|
| 1986
|
Mononuclear phagocyte function in SLE. I. Bipartite Fc- and complement-dependent dysfunction.
Journal of Immunology.
137:91-96.
1986
|
|
| 1986
|
Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
Journal of Immunology.
137:97-102.
1986
|
|
| 1986
|
Phagocytosis of concanavalin A-treated erythrocytes is mediated by the FCγ receptor.
Journal of Immunology.
137:456-462.
1986
|
|
| 1985
|
Elevation of platelet associated antibody levels in patients with chronic idiopathic thrombocytopenic purpura expressing the B8 and/or DR3 allotypes.
Tissue Antigens: immune response genetics.
26:132-137.
1985
|
|
| 1984
|
Defective mononuclear phagocyte function in systemic lupus erythematosus: Dissociation of Fc receptor-ligand binding and internalization.
Journal of Immunology.
133:2525-2531.
1984
|
|
| 1984
|
Modulation of mononuclear phagocyte function by intravenous γ-globulin.
Journal of Immunology.
132:745-750.
1984
|
|
| 1984
|
Hemophilia, antineoplastic factor, and immune complexes.
Annals of Internal Medicine.
100:915-916.
1984
|
|
| 1984
|
Modulation of mononuclear phagocyte system function and circulating immune complexes by lyophilized concentrates in patients with classic hemophilia.
Clinical immunology and immunopathology.
31:321-330.
1984
|
|
| 1983
|
End-Stage Renal Disease in Systemic Lupus Erythematosus.
New England Journal of Medicine.
308:1537-1539.
1983
|
|
| 1983
|
Impaired Fc-mediated mononuclear phagocyte system clearance in HLA-DR2 and MT1-positive healthy young adults.
Journal of Experimental Medicine.
157:1698-1703.
1983
|
|
| 1983
|
Dynamics of mononuclear phagocyte system Fc receptor function in systemic lupus erythematosus. Relation to disease activity and circulating immune complexes.
Clinical and Experimental Immunology.
51:261-268.
1983
|
|
| 1983
|
Endocytosis by the mononuclear phagocyte system and autoimmune disease.
American Journal of Medicine.
74:481-493.
1983
|
|
| 1983
|
Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura.
Blood.
62:480-486.
1983
|
|
| 1983
|
Reversible "end-stage" lupus nephritis. Analysis of patients able to discontinue dialysis.
American Journal of Medicine.
74:361-368.
1983
|
|
| 1983
|
Reversible 'end-stage' lupus nephritis. Analysis of patients able to discontinue dialysis.
American Journal of Medicine.
74:361-368.
1983
|
|
| 1983
|
Serial circulating immune complexes and mononuclear phagocyte system function in infective endocarditis.
Translational Research: the journal of laboratory and clinical medicine.
102:947-959.
1983
|
|
| 1982
|
Pulse methylprednisolone in SLE..
Clinics in rheumatic diseases.
8:261-278.
1982
|
|
| 1982
|
A serial study of splenic reticuloendothelial system fc receptor functional activity in systemic lupus erythematosus.
Arthritis and Rheumatism.
25:48-54.
1982
|
|
| 1982
|
Acute pancreatitis in systemic lupus erythematosus: Report of twenty cases and a review of the literature.
Medicine.
61:25-32.
1982
|
|
| 1982
|
Comparative effects of aspirin and ibuprofen in the management of systemic Lupus erythematosus
1982
|
|
| 1982
|
Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritis.
Annals of Internal Medicine.
97:526-532.
1982
|
|
| 1981
|
Acute Effects of Aspirin and Acetaminophen on Renal Function.
Archives of Internal Medicine.
141:343-348.
1981
|
|
| 1981
|
Acute effects of aspirin and acetaminophen on renal function..
Archives of Internal Medicine.
141:343-348.
1981
|
|
| 1981
|
Acute corticosteroid-induced depression of renal function in systemic lupus erythematosus (SLE): Association with decreased renal prostaglandin synthesis.
Arthritis and Rheumatism.
24:300.
1981
|
|
| 1981
|
End-stage lupus nephritis: Clinical course to and outcome on dialysis: Experience with 39 patients.
Medicine.
60:277-287.
1981
|
|
| 1981
|
High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus.
American Journal of Medicine.
70:817-824.
1981
|
|
| 1980
|
Comparative effects of aspirin and ibuprofen in the management of systemic lupus erythematosus.
Arthritis and Rheumatism.
23:1401-1404.
1980
|
|
| 1980
|
Dynamics of renal function in lupus nephritis: predictive value and implications of drug-induced transient changes.
Arthritis and Rheumatism.
23:703.
1980
|
|
| 1980
|
Great reduction in renal function associated with cimetidine.
Arthritis and Rheumatism.
23:614-615.
1980
|
|
| 1979
|
Renal changes in systemic lupus erythematosus..
Archives of Internal Medicine.
139:1062.
1979
|
|
| 1979
|
Fc-receptor dysfunction in lupus..
New England Journal of Medicine.
300:1487.
1979
|
|
| 1979
|
Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus.
New England Journal of Medicine.
300:518-523.
1979
|
|
| 1979
|
Treatment of Lupus Nephritis with Combined Therapy.
New England Journal of Medicine.
300:564-565.
1979
|
|
| 1979
|
Acute corticosteroid-induced depression of renal function in systemic lupus erythematosus.
Arthritis and Rheumatism.
22:629-630.
1979
|
|
| 1979
|
Apparent acute renal failure associated with therapeutic aspirin and ibuprofen administration.
Arthritis and Rheumatism.
22:281-285.
1979
|
|
| 1979
|
Clinical efficacy of high dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus.
Arthritis and Rheumatism.
22:629.
1979
|
|
| 1979
|
Presumptive autonephrectomy in scleroderma.
Arthritis and Rheumatism.
22:305-305.
1979
|
|
| 1979
|
Renal Changes in Systemic Lupus Erythematosus.
Archives of Internal Medicine.
139:1062.
1979
|
|
| 1979
|
Stable model immune complexes produced by bivalent affinity labeling haptens: In-vivo survival.
Molecular Immunology.
16:721-729.
1979
|
|
| 1978
|
RENAL PROSTAGLANDINS IN SYSTEMIC LUPUS ERYTHEMATOSUS.
The Lancet.
312:553-555.
1978
|
|
| 1978
|
Elevated urinary prostaglandins and the effect of aspirin on renal function in lupus erythematosus.
Annals of Internal Medicine.
89:336-341.
1978
|
|
| 1978
|
Exacerbation of Phenylbutazone-Related Renal Failure by Indomethacin.
Archives of Internal Medicine.
138:1711-1712.
1978
|
|
| 1978
|
Increased risk of lymphoma in sicca syndrome.
Annals of Internal Medicine.
89:888-892.
1978
|
|
| 1978
|
Reduction of renal function by newer nonsteroidal anti-inflammatory drugs.
American Journal of Medicine.
64:804-807.
1978
|
|
| 1977
|
Aspirin and Renal Function.
New England Journal of Medicine.
296:1168-1169.
1977
|
|
| 1977
|
Aspirin-Induced Depression of Renal Function.
New England Journal of Medicine.
296:418-424.
1977
|
|
| 1976
|
Effect of salicylates on creatinine clearance.
British medical journal.
2:421-422.
1976
|
|
| 1971
|
Response characteristics of pigeon forebrain cells to visual stimulation.
Vision Research.
11:475-478.
1971
|
|
| 1970
|
Rhythmic patterns in human interaction.
Nature.
228:88-90.
1970
|
|
